Propanc Biopharma, Inc.

PPCB ·Healthcare, Drug Manufacturers - General, Australia
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-K Sep 30, 2024
8-K Sep 27, 2024
8-K Aug 30, 2024
DEF 14C Aug 22, 2024
8-K Aug 15, 2024
PRE 14C Aug 8, 2024
8-K Aug 7, 2024
8-K Jul 2, 2024
8-K Jun 21, 2024
8-K/A Jun 13, 2024
8-K Jun 12, 2024
8-K Jun 5, 2024
8-K May 16, 2024
10-Q May 15, 2024
8-K Apr 22, 2024
8-K Apr 10, 2024
8-K Mar 11, 2024
10-Q Feb 20, 2024
NT 10-Q Feb 14, 2024
8-K Dec 15, 2023
8-K Dec 7, 2023
10-Q Nov 14, 2023
D Nov 3, 2023
8-K Oct 30, 2023
8-K Oct 26, 2023
← Newer Page 4 of 18 · 434 filings Older →